User menu

Erratum: Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Bibliographic reference Hendlisz, Alain ; Golfinopoulos, Vassilis ; Deleporte, Amelie ; Paesmans, Marianne ; El Mansy, Hazem ; et. al. Erratum: Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.. In: BMC Cancer, Vol. 15, no.1, p. 173 (2015)
Permanent URL http://hdl.handle.net/2078.1/175953
  1. Hendlisz Alain, Golfinopoulos Vassilis, Deleporte Amelie, Paesmans Marianne, Mansy Hazem El, Garcia Camilo, Peeters Marc, Annemans Lieven, Vandeputte Caroline, Maetens Marion, Borbath Ivan, Dresse Damien, Houbiers Ghislain, Fried Michael, Awada Ahmad, Piccart Martine, Laethem Jean-Luc Van, Flamen Patrick, Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study, 10.1186/1471-2407-13-190